Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 901–1,000 of 1,062
Hosoya, T., Hiramatsu, T., Ikemoto, T., Nakanishi, M., Aoyama, H., Hosoya, A., Iwata, T., Maruyama, K., Endo, M., & Suzuki, M. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b316221d · Cited by 102
Gopalan, A., Yu, W., Sanders, B. G., & Kline, K. A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.031 · Cited by 103
“These mevalonate-derived prenyl groups exert pleiotropic effects on many essential cellular functions including cell proliferation, differentiation, and survival [5–7].”
BackgroundThe H295R system for evaluation of endocrine-disrupting effects
Gracia, T., Hilscherová, K., Jones, P. D., Newsted, J. L., Zhang, X., Hecker, M., Higley, E. B., Sanderson, J. T., Yu, R. M. K., Wu, R. S. S., et al. (2006) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2006.06.012 · Cited by 109
“…models, the reaction catalyzed by HMGR is the rate-limiting step in cholesterol biosynthesis and is subject to complex ARTICLE IN PRESS T. Gracia et al. / Ecotoxicology and Environmental Safety 65 (2006) 293–305300 Au th or 's pe rs on al co py regulatory controls (Goldstein and Brown, 1990).”
BackgroundCaldas, H. C., & Herman, G. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg321 · Cited by 103
Willey, J. Z., & Elkind, M. S. V. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.199 · Cited by 102
“3-Hydroxy-3-methylglutaryl–coenzyme A (HMG-CoA) reductase inhibitors, also known as statins, act on the rate-limiting step in the pathway by which HMG-CoA is converted to mevalonate.(1) Through their effect on this pathway (Figure), as well as an increase in low-density lipoprotein cholesterol (LDL-C) receptors and up…”
BackgroundMitochondrial cholesterol in health and disease.
García‐Ruiz, C., Marí, M., Colell, A., Morales, A., Caballero, F., Montero, J., Terrones, O., Basáñez, G., & Fernández-Checa, J. C. (2009) · PubMed · doi:10.14670/hh-24.117 · Cited by 111
“The enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase (HMGCoAR) catalyzes the reduction of HMG CoA to mevalonate, the rate-limiting step in the synthesis of cholesterol and nonsterol isoprenoids that are indispensable for cell function (Goldstein and Brown, 1990).”
BackgroundKoivisto, U. M., Palvimo, J. J., Jänne, O. A., & Kontula, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10526 · Cited by 102
Inhibitors of squalene biosynthesis and metabolism
Abe, I., Tomesch, J. C., Wattanasin, S., & Prestwich, G. D. (1994) · Natural Product Reports · doi:10.1039/np9941100279 · Cited by 101
Targeting the Mevalonate Pathway Inhibits the Function of the Epidermal Growth Factor Receptor
Mantha, A. J., Hanson, J. E. L., Goss, G., Lagarde, A. E., Lorimer, I. A., & Dimitroulakos, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1951 · Cited by 101
“which covalent binding to proteins such as ras facilitates their membrane localization; and dolichol, required for glycoprotein synthesis (17).”
BackgroundGenomic Convergence among ERRα, PROX1, and BMAL1 in the Control of Metabolic Clock Outputs
Dufour, C. R., Levasseur, M.-P., Pham, N. H. H., Eichner, L. J., Wilson, B. J., Charest-Marcotte, A., Duguay, D., Poirier-Héon, J.-F., Cermakian, N., & Giguère, V. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002143 · Cited by 102
“, encoding the rate-limiting enzyme HMG-CoA reductase in cholesterol biosynthesis”
BackgroundKidera, Y., Tsubaki, M., Yamazoe, Y., Shoji, K., Nakamura, H., Ogaki, M., Satou, T., Itoh, T., Isozaki, M., Kaneko, J., et al. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-127 · Cited by 99
“HMG-CoA reductase inhibitors (statins) are reversible inhibitors of the rate-limiting step in cholesterol biosynthesis [17].”
Nemes, K., Åberg, F. O., Gylling, H., & Isoniemi, H. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i22.924 · Cited by 112
Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview
Salerno-Kennedy, R., & Cashman, K. D. (2005) · Wiener klinische Wochenschrift · doi:10.1007/s00508-005-0336-9 · Cited by 102
“In malignant and premalignant conditions an uncontrolled synthesis of mevalonate has been found, due to a loss of cholesterol feedback control [46, 47 ].”
BackgroundHarker, M., Holmberg, N., Clayton, J. C., Gibbard, C. L., Wallace, A. D., Rawlins, S., Hellyer, S. A., Lanot, A., & Safford, R. (2003) · Plant Biotechnology Journal · doi:10.1046/j.1467-7652.2003.00011.x · Cited by 100
Choi, P., & Chen, C. (2005) · Cancer · doi:10.1002/cncr.21293 · Cited by 110
Synthesis and function of isopentenyl adenosine derivatives in tRNA
Persson, B. C., Esberg, B., Ólafsson, Ó., & Björk, G. R. (1994) · Biochimie · doi:10.1016/0300-9084(94)90044-2 · Cited by 109
Banker, D. E., Mayer, S. J., Li, H. Y., Willman, C. L., Appelbaum, F. R., & Zager, R. A. (2004) · Blood · doi:10.1182/blood-2004-01-0395 · Cited by 100
Knox, J. J., Siu, L. L., Chen, E. X., Dimitroulakos, J., Kamel‐Reid, S., Moore, M. J., Chin, S. F., Irish, J., Laframboise, S., & Oza, A. M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.013 · Cited by 101
“1) [7].”
BackgroundModulation of COX-2 Expression by Statins in Human Aortic Smooth Muscle Cells
Degraeve, F., Bolla, M., Blaie, S., Créminon, C., Quéré, I., Boquet, P., Levy-Toledano, S., Bertoglio, J. H., & Habib, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104197200 · Cited by 100
Hehl, A. B., Marti, M., & Kohler, P. O. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.5.1789 · Cited by 100
“This sequence has been hypothesized to be a sterol regulatory element (Lujan et al., 1997), involved in cholesterol-sensitive transcription regulation ( Goldstein and Brown, 1990; Vallett et al., 1996; Bist et A.B.”
BackgroundEricsson, J., Jackson, S. M., & Edwards, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24359 · Cited by 100
Kumagai, H., Chun, K. T., & Simoni, R. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.19107 · Cited by 100
Cholesterol: A Gatekeeper of Male Fertility?
Sèdes, L., Thirouard, L., Maqdasy, S., Garcia, M., Caira, F., Lobaccaro, J. A., Beaudoin, C., & Volle, D. H. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00369 · Cited by 105
“Within the body, the liver plays an important role in maintaining cholesterol homeostasis by regulating absorption and synthesis to prevent over accumulation in the plasma and tissues (10, 11) (Figure 1).”
BackgroundJougasaki, M., Ichiki, T., Takenoshita, Y., & Setoguchi, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00612.x · Cited by 98
“These isoprenoids are necessary for the post-translational isoprenylation of various proteins that are involved in cell signalling pathways (Goldstein and Brown, 1990; Casey, 1995).”
BackgroundAntioxidative effects of statins
Adam, O., & Laufs, U. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0344-4 · Cited by 108
“reductase reduces the synthesis of intermediates of the mevalonate pathway (Goldstein and Brown 1990).”
InfluentialRoitelman, J., & Simoni, R. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74035-6 · Cited by 100
Isoprenoid metabolism and the pleiotropic effects of statins
Laufs, U., & Liao, J. K. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0008-z · Cited by 100
“Inhibition of mevalonate synthesis reduces cholesterol synthesis as well as synthesis of the isoprenoid intermediates of the cholesterol synthesis pathway, such as farnesol and geranylgeraniol [ 10 ].”
BackgroundSanford, J. C., Codina, J., & Birnbaumer, L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92858-9 · Cited by 107
Genetic Dissection of Synthesis and Function of Modified Nucleosides in Bacterial Transfer RNA
Björk, G. R. (1995) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60817-x · Cited by 121
de Bittencourt, P. I. H., Lagranha, D. J., Maslinkiewicz, A., Senna, S. M., Tavares, Â. M. V., Baldissera, L. P., Janner, D. D. R., Peralta, J. D. S., Bock, P. M., Gutierrez, L. L. P., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.049 · Cited by 98
“CP-PG treatment and HMG-CoA reductase mRNA expression was even enhanced, at the same time that PGA2 deviated cholesterogenesis towards the synthesis of phospholipids, it is possible that PGA2 inhibiting effect on cholesterogenesis should be due to a strong influence on HMG-CoA reductase activation status [ 36 ], but n…”
BackgroundSimvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs
Mital, S. R., Zhang, X., Zhao, G., Bernstein, R. D., Smith, C. J., Fulton, D. J., Sessa, W. C., Liao, J. K., & Hintze, T. H. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.6.h2649 · Cited by 98
Bergman, A. J., Murphy, G., Burke, J., Zhao, J. J., Valesky, R., Liu, L., Lasseter, K. C., He, W., Prueksaritanont, T., Qiu, Y., et al. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004268044 · Cited by 97
“Thus, simvastatin acid and other active metabolites effectively inhibit the conversion of HMG-CoA to mevalonate, which is an early and rate-limiting step in the biosynthesis of cholesterol.(7)”
BackgroundCholesterol-independent Effects of Statins and New Therapeutic Targets: Ischemic Stroke and Dementia
Miida, T., Hirayama, S., & Nakamura, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.253 · Cited by 97
Pharmacological treatment and therapeutic perspectives of metabolic syndrome
Lim, S. K., & Eckel, R. H. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9298-4 · Cited by 103
“Statins are competitive inhibitors of HMG-CoA reductase, blocking the rate-limiting step in cholesterol biosynthesis [77].”
BackgroundExploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma
Clendening, J. W., Pandyra, A., Li, Z., Boutros, P. C., Martirosyan, A., Lehner, R., Jurisica, I., Trudel, S., & Penn, L. Z. (2010) · Blood · doi:10.1182/blood-2009-07-230508 · Cited by 100
Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis
Rao, C. V., Newmark, H. L., & Reddy, B. S. (2002) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(02)00119-8 · Cited by 97
Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia
Raal, F. J., Pilcher, G. J., Illingworth, D. R., Pappu, A. S., Stein, E. A., Laskarzewski, P. M., Mitchel, Y., & Melino, M. R. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00168-8 · Cited by 97
“Inherited differences in sterol-mediated regulation of HMG CoA reductase activity [38] or variability in the efficiency of either drug absorption or hepatic metabolism are potential factors which warrant further study.”
BackgroundKumar, M., Rakesh, S., Nagpal, R., Hemalatha, R., Ramakrishna, A. V. S., Sudarshan, V., Ramagoni, R., Shujauddin, M., Verma, V., Kumar, A., et al. (2013) · Nutrition · doi:10.1016/j.nut.2012.09.006 · Cited by 108
“A regulatory enzyme, HMG-CoA reductase, in the cholesterol synthesis pathway catalyzes the synthesis of mevalonate from HMG-CoA [29] and is regulated at the post-transcriptional level.”
BackgroundLiu, W., Xu, X., Zhang, R., Cheng, T., Cao, Y., Li, X., Guo, J., Liu, H., & Xian, M. (2016) · Biotechnology for Biofuels · doi:10.1186/s13068-016-0466-5 · Cited by 96
“Geraniol is derived from geranyl diphosphate (GPP) which is synthesized from either the mevalonate (MVA) pathway or the methylerythritol phosphate pathway in plants [6, 7].”
BackgroundEngineering microbes for isoprene production
Ye, L., Lv, X., & Yu, H. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.07.005 · Cited by 103
BTS1 Encodes a Geranylgeranyl Diphosphate Synthase in Saccharomyces cerevisiae
Jiang, Y., Proteau, P., Poulter, C. D., & Ferro‐Novick, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21793 · Cited by 97
“These lipid precursors are intermediates in the isoprenoid biosynthetic pathway (Goldstein and Brown, 1990).”
BackgroundSumi, D., Hayashi, T., Thakur, N. K., Jayachandran, M., Asai, Y., Kano, H., Matsui, H., & Iguchi, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00597-9 · Cited by 101
“3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors (statins) are potent inhibitors of cholesterol biosynthesis in the liver by blocking the conversion of HMG-CoA to mevalonate [1,2].”
BackgroundBiochemistry and Molecular Biology of Sterol Synthesis in Saccharomyces cerevisiae
Lees, N. D., Bard, M., & Kirsch, D. R. (2020) · BIOCHEMISTRY and FUNCTION of STEROLS · doi:10.1201/9781003068754-6 · Cited by 98
A Latex Metabolite Benefits Plant Fitness under Root Herbivore Attack
Huber, M., Epping, J., Schulze Gronover, C., Fricke, J., Aziz, Z., Brillatz, T., Swyers, M., Köllner, T. G., Vogel, H., Hammerbacher, A., et al. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002332 · Cited by 97
“The substrate FDP is a common precursor for sesquiterpenes, triterpenes, and phytosterols [48,49], and the farnesyl residue can bind to growth-regulating proteins of the ras family [50].”
BackgroundTargeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies
Coppens, I. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3139 · Cited by 96
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer
Longo, J., Mullen, P. J., Yu, R., van Leeuwen, J. E., Masoomian, M., Woon, D. T. S., Wang, Y., Chen, E. X., Hamilton, R. J., Sweet, J. M., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.04.003 · Cited by 98
“The depletion of sterols typically leads to the cleavage and activation of the SREBP transcription factors, which subsequently activate the transcription of MVA pathway genes, thus restoring MVA pathway activity [30,34].”
BackgroundEndoplasmic reticulum stress and lipid dysregulation
Colgan, S. M., Al-Hashimi, A. A., & Austin, R. C. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001742 · Cited by 98
Cao, J. P., Wang, J., Qi, W., Miao, H., Wang, J., Ge, L., DeBose‐Boyd, R. A., Tang, J.-J., Li, B.-L., & Song, B. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.07.002 · Cited by 98
“The enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) catalyzes the reduction of HMG-CoA to mevalonate, a rate-limiting step in the synthesis of cholesterol (Goldstein and Brown, 1990).”
BackgroundHMG-CoA Reductase Inhibitors Inhibit Inducible Nitric Oxide Synthase Gene Expression in Macrophages
Huang, K., Chen, C., Chen, J.-C., & Lin, W. (2003) · Journal of Biomedical Science · doi:10.1007/bf02256431 · Cited by 96
“isoprenylation, of several proteins in the signal transduction pathway, such as Rho, Rac, Cdc42, Ras, Rap and Rab [ 21-23 , 46, 55].”
BackgroundMembrane Topology of Human Insig-1, a Protein Regulator of Lipid Synthesis
Feramisco, J. D., Goldstein, J. L., & Brown, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312623200 · Cited by 98
Self-citationProtein prenylation in eukaryotic microorganisms: genetics, biology and biochemistry
Omer, C. A., & Gibbs, J. B. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00302.x · Cited by 97
Deng, X., Guo, D., Yang, S., Shi, M., Chao, J., Li, H., Peng, S.-Q., & Weimin, T. (2018) · Journal of Experimental Botany · doi:10.1093/jxb/ery169 · Cited by 95
An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia
Gesto, D., Pereira, C. M. S. B., Cerqueira, N. M. F. S. A., & Sousa, S. F. (2020) · Molecules · doi:10.3390/molecules25173891 · Cited by 119
“This process requires several steps, which can be summarized in four stages: synthesis of mevalonate (Figure 3a); conversion of mevalonate to activated isoprenes (Figure 3b); formation of squalene (Figure 3c); and ring closure of squalene to form the sterol ring system (Figure 3d) [19,20].”
BackgroundDaraselia, N., Tarchevskaya, S. S., & Narita, J. O. (1996) · PLANT PHYSIOLOGY · doi:10.1104/pp.112.2.727 · Cited by 95
Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases
Ghasemi, M., & Fatemi, A. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.002 · Cited by 120
Scharnagl, H., Schinker, R., Gierens, H., Nauck, M., Wieland, H., & März, W. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00790-0 · Cited by 105
Microarray and Biochemical Analysis of Lovastatin-induced Apoptosis of Squamous Cell Carcinomas
Dimitroulakos, J., Marhin, W. H., Tokunaga, J., Irish, J., Gullane, P. J., Penn, L. Z., & Kamel‐Reid, S. (2002) · Neoplasia · doi:10.1038/sj.neo.7900247 · Cited by 97
“Farnesyl transferase and geranylgeranyl transferases utilize FPP and GGPP, respectively, for posttranslational isoprenylation of proteins [16,33].”
BackgroundInfluentialKim, S., Sohn, I., Sook, L. Y., & Lee, Y. S. (2005) · Journal of Nutrition · doi:10.1093/jn/135.1.33 · Cited by 109
Rawson, R. B., Cheng, D., Brown, M. S., & Goldstein, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28261 · Cited by 96
Self-citationLi, J., Ding, L., Song, B., Xu, X., Meng, Q., Yang, Q., Yang, Q., Tang, X., Wang, Z., & Yang, L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.045 · Cited by 100
Yang, J., Brown, M. S., Ho, Y. K., & Goldstein, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12152 · Cited by 95
Self-citationKnapp, A. C., Huang, J., Starling, G. C., & Kiener, P. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00462-1 · Cited by 95
“Since these effects were reversed with mevalonate and other metabolites of the isoprene synthesis pathway, protein prenylation seems to play an important role [13].”
BackgroundInhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)
Hidaka, Y., Eda, T., Yonemoto, M., & Kamei, T. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90179-k · Cited by 95
Ionone Is More than a Violet’s Fragrance: A Review
Aloum, L., Alefishat, E. A., Adem, A., & Petroianu, G. A. (2020) · Molecules · doi:10.3390/molecules25245822 · Cited by 108
“Mevalonate is a precursor of sterol molecules such as cholesterol and nonsterol isoprenoids such as dolichol, ubiquinone, farnesyl pyrophosphate and geranylgeranyl pyrophosphate [94].”
BackgroundStatin use in patients with asthma - a nationwide population-based study
Huang, C., Chan, W., Chen, Y., Chen, T., Chou, K., Lin, S., Chen, J., & Leu, H. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02434.x · Cited by 95
Pradeep, A. R., Rao, N. S., Bajaj, P., & Kumari, M. (2013) · Journal of Periodontology · doi:10.1902/jop.2012.110721 · Cited by 92
Johnston, P. A., Archer, B. T., Robinson, K., Mignery, G. A., Jahn, R., & Südhof, T. C. (1991) · Neuron · doi:10.1016/0896-6273(91)90078-e · Cited by 101
Laaksonen, R., Ojala, J.-P., Tikkanen, M. J., & Himberg, J. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00194398 · Cited by 94
“Apart from being a key intermediate in cholesterol biosynthesis, mevalonate is a precursor for several nonsterol isoprenoid compounds [8].”
BackgroundSen, S. E., Jull, S., & Whelchel, R. (2003) · Elsevier eBooks · doi:10.1016/b0-12-341103-3/00186-8 · Cited by 94
Statins: a role in breast cancer therapy?
Borgquist, S., Bjarnadottir, O., Kimbung, S., & Ahern, T. P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12806 · Cited by 101
Wang, L. W., Wang, Z., Ersing, I., Nobre, L., Guo, R., Jiang, S., Trudeau, S. J., Zhao, B., Weekes, M. P., & Gewurz, B. E. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008030 · Cited by 100
“HMGCR is the rate-limiting enzyme of the mevalonate pathway [37], which branches to produce either cholesterol or isoprenoids (Fig 3C).”
BackgroundNiemann–Pick C1-Like 1 and cholesterol uptake
Wang, L.-J., & Song, B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.03.004 · Cited by 106
“The cholesterol biosynthesis is a well-defined energy-consuming and feedback-regulated process, which involves at least 20 enzymatic reactions [4].”
BackgroundXu, Y., Liu, Y., Ridgway, N. D., & McMaster, C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101204200 · Cited by 94
Ubiquitin-proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase
Kato, H., Sakaki, K., & Mihara, K. (2006) · Journal of Cell Science · doi:10.1242/jcs.02951 · Cited by 97
“In particular, cellular sterol levels exert feed-back regulation on HMGR in the ER through multiple mechanisms; high sterol levels shut-down transcription of the HMGR gene concomitant with accelerated protein degradation (Goldstein and Brown, 1990).”
BackgroundRapid immunomodulation by rosuvastatin in patients with acute coronary syndrome
Link, A., Ayadhi, T., Böhm, M., & Nickenig, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl277 · Cited by 96
The Proteasome: A Central Regulator of Inflammation and Macrophage Function
Qureshi, N., Vogel, S. N., Way, C. W. V., Papasian, C. J., Qureshi, A. A., & Morrison, D. C. (2005) · Immunologic Research · doi:10.1385/ir:31:3:243 · Cited by 103
Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation
Matsubara, K., Kishida, S., Matsuura, Y., Kitayama, H., Noda, M., & Kikuchi, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202425 · Cited by 113
“The post-translational modi®cation of Ras has been extensively studied (Hancock et al., 1989; Goldstein and Brown, 1990; Takai et al., 1992; Lowy and Willumsen, 1993).”
BackgroundKim, J.-H., Wang, C., Jang, H.-J., Cha, M.-S., Park, J., Jo, S.-Y., Choi, E., & Kim, S.-W. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0612-6 · Cited by 96
Monogenic Dyslipidemias: Window on Determinants of Plasma Lipoprotein Metabolism
Hegele, R. A. (2001) · The American Journal of Human Genetics · doi:10.1086/324647 · Cited by 104
“The cholesterol biosynthetic pathway involves numerous enzymes and bioactive intermediates (Goldstein and Brown 1990).”
BackgroundBradfute, D. L., & Simoni, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37422-7 · Cited by 93
Ludka, F. K., Zomkowski, A. D. E., Cunha, M. P., Dal-Cim, T., Zeni, A. L. B., Rodrigues, A. L. S., & Tasca, C. I. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.005 · Cited by 92
Hampton, R. Y., & Garza, R. M. (2009) · Chemical Reviews · doi:10.1021/cr800544v · Cited by 92
Terpenoid Metabolic Engineering in Photosynthetic Microorganisms
Vavitsas, K., Fabris, M., & Vickers, C. (2018) · Genes · doi:10.3390/genes9110520 · Cited by 91
“The MVA pathway is limited by the first catalytic steps—from acetyl-coA to mevalonate—and in particular by the 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGR) [32,33].”
BackgroundCholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma
Ahmad, F., Sun, Q., Patel, D., & Stommel, J. M. (2019) · Cancers · doi:10.3390/cancers11020146 · Cited by 93
Cholesterol homeostasis: Researching a dialogue between the brain and peripheral tissues
Gliozzi, M., Musolino, V., Bosco, F., Scicchitano, M., Scarano, F., Nucera, S., Zito, M. C., Ruga, S., Carresi, C., Macrì, R., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105215 · Cited by 101
Genome-wide association studies of cardiovascular disease
Walsh, R., Jurgens, S. J., Erdmann, J., & Bezzina, C. R. (2023) · Physiological Reviews · doi:10.1152/physrev.00024.2022 · Cited by 102
Molecular markers and targets for colorectal cancer prevention
Janakiram, N. B., & Rao, C. V. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00742.x · Cited by 94
Kim, Y. S., Cho, J. H., Park, S., Han, J.-Y., Back, K., & Choi, Y.-E. (2010) · Planta · doi:10.1007/s00425-010-1292-9 · Cited by 92
“Two molecules of farnesyl pyrophosphate (FPP) are condensed to form squalene via SS (Goldstein and Brown 1990; Abe et al. 1993; Fig.”
BackgroundFujii, M., Inoguchi, T., Maeda, Y., Sasaki, S., Sawada, F., Saito, R., Kobayashi, K., Sumimoto, H., & Takayanagi, R. (2007) · Kidney International · doi:10.1038/sj.ki.5002366 · Cited by 95
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models
Shibata, M. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.453 · Cited by 92
Enjuto, M., Lumbreras, V., Marín, C., & Boronat, A. (1995) · The Plant Cell · doi:10.1105/tpc.7.5.517 · Cited by 92
“However, HMGP gene expression in meristematic tissues might also be related to protein prenylation, a process that has been related tocell growth and division (Brown and Goldstein, 1980; Glomset et al., 1990; Goldstein and Brown, 1990; Maltese, 1990).”
The 3‐methylglutaconic acidurias: what's new?
Wortmann, S. B., Kluijtmans, L. A. J., Engelke, U. F. H., Wevers, R. A., & Morava, É. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9210-7 · Cited by 92
“Low plasma cholesterol can induce HMG-CoA synthase, leading to increased HMG-CoA levels and an increased flux through the cholesterol biosynthesis pathway (Goldstein and Brown 1990).”
BackgroundHypolipidemic Effect of Triphala in Experimentally Induced Hypercholesteremic Rats
Selvaraj, S., SRIKUMAR, R., Manikandan, S., Parthasarathy, N. J., & Devi, R. S. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.385 · Cited by 92
Flint, O. P., Masters, B. A., Gregg, R. E., & Durham, S. K. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8174 · Cited by 92
Smith‐Lemli‐Opitz Syndrome and the DHCR7 Gene
Jira, P. E., Waterham, H. R., Wanders, R. J. A., Smeitink, J. A. M., Sengers, R. C. A., & Wevers, R. A. (2003) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2003.00034.x · Cited by 92
“Cholesterol is the main endproduct derived from the isoprenoid biosynthetic pathway (Goldstein & Brown, 1990).”
BackgroundOptimal Windows of Statin Use for Immediate Infarct Limitation
Sanada, S., Asanuma, H., Minamino, T., Node, K., Takashima, S., Okuda, H., Shinozaki, Y., Ogai, A., Fujita, M., Hirata, A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143830.59419.73 · Cited by 92
“13,17 We and others have shown that (1) adenosine receptor (A1 and A2) activation improves contractile dysfunction after reperfusion,14 (2) inhibition of norepinephrine release from the presynaptic vesicles and attenuation of calcium influx occur through the A1 receptor and the coupled inhibitory G protein,33,34 (3) i…”
BackgroundResultCell Compartmentalization of Cholesterol Biosynthesisa
KRISANS, S. K. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18614.x · Cited by 93
Sun, L., Ren, L., Zhuang, X., Ji, X., Yan, J., & Huang, H. (2014) · Bioresource Technology · doi:10.1016/j.biortech.2014.02.106 · Cited by 94
Marsafari, M., & Xu, P. (2020) · Metabolic Engineering Communications · doi:10.1016/j.mec.2019.e00121 · Cited by 97
“HMG1, a rate-limiting step of the mevalonate pathway, catalyzes the reduction of HMG-CoA to mevalonate and is the key enzyme in the mevalonate pathway (Goldstein and Brown, 1990).”
BackgroundAthanikar, J. N., Sanchez, H. B., & Osborne, T. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5193 · Cited by 88
“Cellular sterol balance is maintained by a feedback mechanism primarily at the level of gene transcription (3, 9, 28).”
Background
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.